APA (7th ed.) Citation

Bruxelles, Q., Hamel-Côté, G., Scott-Boyer, M., Ouellette, V., C.-Gaudreault, R., Durocher, F., . . . Fortin, S. (2026). FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938. Pharmaceuticals (14248247), 19(3), 357. https://doi.org/10.3390/ph19030357

Chicago Style (17th ed.) Citation

Bruxelles, Quentin, Geneviève Hamel-Côté, Marie-Pier Scott-Boyer, Vincent Ouellette, René C.-Gaudreault, Francine Durocher, Caroline Diorio, Arnaud Droit, and Sébastien Fortin. "FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938." Pharmaceuticals (14248247) 19, no. 3 (2026): 357. https://doi.org/10.3390/ph19030357.

MLA (9th ed.) Citation

Bruxelles, Quentin, et al. "FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938." Pharmaceuticals (14248247), vol. 19, no. 3, 2026, p. 357, https://doi.org/10.3390/ph19030357.